118 HR 5801 IH: Preventing Overdoses with Test Strips Act U.S. House of Representatives 2023-09-28 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.

I118th CONGRESS1st SessionH. R. 5801IN THE HOUSE OF REPRESENTATIVESSeptember 28, 2023Mr. Gottheimer (for himself, Mr. Bacon, and Mr. Gallego) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo ensure that expenses relating to the acquisition or use of devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances, including test strips, are allowable expenses under certain grant programs.

1.

Short title

This Act may be cited as the Preventing Overdoses with Test Strips Act.

2.

Amending the 21st Century Cures Act to authorize the use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances

Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3a) is amended—(1)in subsection (b)(4), by adding at the end the following:(G)Providing assistance for expenses relating to the acquisition or use of adulterant substance detection devices. ; and(2)in subsection (h)—(A)by redesignating paragraphs (1) through (4) as paragraphs (2) through (5), respectively; and(B)by inserting before paragraph (2) (as so redesignated), the following: (1)

Adulterant substance detection device

The term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance..

3.

Amending the Public Health Service Act to authorize the use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances

Part A of title V of the Public Health Service Act (42 U.S.C. 290aa et seq.) is amended by adding at the end the following:

506B.

Use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances

(a)

In general

Expenses relating to the acquisition or use of adulterant substance detection devices shall be allowable expenses under any grant, contract, or cooperative agreement entered into by the Substance Abuse and Mental Health Services Administration under this Act.(b)

Definition

In this section, the term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance.

.